Tumor microenvironmet (TME)

 

Real-Time Monitoring of Cancer Cells in Live Mouse Bone Marrow.

Lee SH, Park SA, Zou Y, Seo SU, Jun CD, Lee WJ, Hyun YM, Cho NH.

Front Immunol. 2018 Aug 2;9:1681.

 

HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer.

Cho SY, Kang S, Kim DS, Na HJ, Kim YJ, Choi YD, Cho NH.

Anticancer Res. 2018 Nov;38(11):6551-6560.

 

An Intrarenal Adrenocortical Carcinoma Arising in an Adrenal Rest.

Lee JH, Choi YD, Cho NH.

J Pathol Transl Med. 2018 Nov;52(6):416-419.

 

Association between pathologic factors and ERG expression in prostate cancer: finding pivotal networking.

Lee SR, Choi YD, Cho NH.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1665-1683.

 

Nodal metastasis signatures in breast cancer.

Park K, Lee JH, Han HH, Mun SG, Kang S, Cha YJ, Koo JS, Kim MJ, Lee HS, Moon J, Cho NH.

Pathol Res Pract. 2017 Jun;213(6):680-687.

 

Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation.

Kim BG, Gao MQ, Kang S, Choi YP, Lee JH, Kim JE, Han HH, Mun SG, Cho NH.

Cell Death Dis. 2017 Mar 2;8(3):e2646.

 

Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.

Lee M, Shin SJ, Oh YT, Jung DC, Cho NH, Choi YD, Park SY.

Eur Radiol. 2017 Sep;27(9):3752-3758.

 

Abdominal seeding of renal cell carcinoma: radiologic, pathologic, and prognostic features.

Park SH, Oh YT, Jung DC, Cho NH, Choi YD, Park SY.

Abdom Radiol (NY). 2017 May;42(5):1510-1516.

 

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression.

Choi JY, Han HH, Kim YT, Lee JH, Kim BG, Kang S, Cho NH.

Yonsei Med J. 2017 Jan;58(1):59-66.

 

Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets.

Kim BG, Kang S, Han HH, Lee JH, Kim JE, Lee SH, Cho NH.

Oncotarget. 2016 May 10;7(19):27468-78.

 

Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.

Han HH, Kim BG, Lee JH, Kang S, Kim JE, Cho NH. Endocr Relat Cancer.

2016 Aug;23(8):609-23.

 

STAT3-induced WDR1 overexpression promotes breast cancer cell migration.

Lee JH, Kim JE, Kim BG, Han HH, Kang S, Cho NH.

Cell Signal. 2016 Nov;28(11):1753-60.

 

Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer.

Shin SJ, Park CK, Park SY, Jang WS, Lee JY, Choi YD, Cho NH.

Virchows Arch. 2016 Sep;469(3):305-12.

 

Lymphangiogenesis in Breast Cancer Correlates with Matrix Stiffness on Shear-Wave Elastography.

Cha YJ, Youk JH, Kim BG, Jung WH, Cho NH.

Yonsei Med J. 2016 May;57(3):599-605.

 

Lipid cell variant of urothelial carcinoma of the kidney with synchronous metastasis to tubular adenoma.

Park CK, Nahm JH, Cho NH.

Pathology. 2016 Jun;48(4):388-90.

 

MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.

Cha YJ, Lee JH, Han HH, Kim BG, Kang S, Choi YD, Cho NH.

Prostate. 2016 Jul;76(10):937-47.

 

Genetic analysis of ovarian microcystic stromal tumor.

Lee JH, Kim HS, Cho NH, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

Obstet Gynecol Sci. 2016 Mar;59(2):157-62.

 

Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.

Lim S, Koh MJ, Jeong HJ, Cho NH, Choi YD, Cho do Y, Lee HY, Rha SY.

Yonsei Med J. 2016 Jul;57(4):831-9.

 

Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.

Park S, Kang SY, Kwon GY, Kwon JE, Kim SK, Kim JY, Kim CH, Kim HJ, Moon KC, Pyo JY, Park WY, Park ES, Sung JY, Sung SH, Oh YH, Lee SE, Lee W, Lee JI, Cho NH, Jung SJ, Cho MS, Cho YM, Cho HY, Cha EJ, Chae YS, Choe G, Choi YJ, Huh J, Ro JY.

Arch Pathol Lab Med. 2016 Nov 7.

 

Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH.
Am J Roentgenol. 2015 Sep;205(3):W328-34.

 

Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations.
Kang S, Kim BG, Han HH, Lee JH, Kim JE, Shim HS, Cho NH.
Oncotarget. 2015 May 30;6(15):13742-9.

 

Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Cha YJ, Jung WH, Cho NH, Koo JS.
Yonsei Med J. 2015 May;56(3):598-607.

 

Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer.
Lee JY, Kang DH, Chung DY, Kwon JK, Lee H, Cho NH, Choi YD, Hong SJ, Cho KS.
World J Mens Health. 2014 Dec;32(3):167-75.

 

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H, Kim KR, Cho NH, Hong SR, Jeong H, Kwon SY, Park KH, An HJ, Kim TH, Kim I, Yoon HK, Suh KS, Min KO, Choi HJ, Park JY, Yoo CW, Lee YS, Lee HJ, Lee WS, Park CS, Lee Y; Gynecological Pathology Study Group of the Korean Society of Pathologists.
World J Surg Oncol. 2014 Nov 8;12:334.

 

3D texture analysis in renal cell carcinoma tissue image grading.
Kim TY, Cho NH, Jeong GB, Bengtsson E, Choi HK.
Comput Math Methods Med. 2014;2014:536217.

 

Renal pelvic urothelial carcinoma with vena caval thrombus mimicking renal cell carcinoma.
Diaz RR, Kwon JK, Lee JY, Nahm JH, Cho KS, Ham WS, Cho NH, Choi YD.
Korean J Urol. 2014 Sep;55(9):624-7.

 

Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.
Kim SK, Song SY, Kim S, Cho NH, Yim GW, Kim SW, Kim YT, Nam EJ.
Int J Clin Exp Pathol. 2014 Jul 15;7(8):5103-10.

 

HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.
Kim SK, Cho NH.
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4222-30

 

Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Cha YJ, Kim YH, Cho NH, Koo JS.
Int J Clin Exp Pathol. 2014 May 15;7(6):3389-98.

 

Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation.
Lee MS, Kim S, Kim BG, Won C, Nam SH, Kang S, Kim HJ, Kang M, Ryu J, Song HE, Lee D, Ye SK, Jeon NL, Kim TY, Cho NH, Lee JW.
Biochim Biophys Acta. 2014 Sep;1843(9):2037-54.

 

Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.
Choi YP, Lee JH, Gao MQ, Kim BG, Kang S, Kim SH, Cho NH.
Int J Cancer. 2014 Nov 1;135(9):2024-33.

 

Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro.
Gao MQ, Kim BG, Kang S, Choi YP, Park H, Kang KS, Cho NH.
J Cell Sci. 2010 Oct 15;123(Pt 20):3507-14.

 

Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets.

STAT3-induced WDR1 overexpression promotes breast cancer cell migration.

Lee JH, Kim JE, Kim BG, Han HH, Kang S, Cho NH.

Cell Signal. 2016 Nov;28(11):1753-60.

 

In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry.
Kang S, Maeng H, Kim BG, Qing GM, Choi YP, Kim HY, Kim PS, Kim Y, Kim YH, Choi YD, Cho NH.
J Proteome Res. 2012 Sep 7;11(9):4567-74.

 

Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.
Kim BG, Gao MQ, Choi YP, Kang S, Park HR, Kang KS, Cho NH.
Breast Cancer Res. 2012 Jun 6;14(3):R88.

 

Proteomic molecular portrait of interface zone in breast cancer.
Kang S, Kim MJ, An H, Kim BG, Choi YP, Kang KS, Gao MQ, Park H, Na HJ, Kim HK, Yun HR, Kim DS,Cho NH.
J Proteome Res. 2010 Nov 5;9(11):5638-45.

 

Molecular proteomics imaging of tumor interfaces by mass spectrometry.
Kang S, Shim HS, Lee JS, Kim DS, Kim HY, Hong SH, Kim PS, Yoon JH, Cho NH.
J Proteome Res. 2010 Feb 5;9(2):1157-64.

 

Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer.
Kim BG, An HJ, Kang S, Choi YP, Gao MQ, Park H, Cho NH.
Am J Pathol. 2011 Jan;178(1):373-81.

 

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.
Gao MQ, Choi YP, Kang S, Youn JH, Cho NH.
Oncogene. 2010 May 6;29(18):2672-80.

 

Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
Cho NH, Shim HS, Rha SY, Kang SH, Hong SH, Choi YD, Hong SJ, Cho SH.
Eur Urol. 2003 Nov;44(5):560-6.

 

Molecular portraits of intratumoral heterogeneity in human ovarian cancer.
Choi YP, Shim HS, Gao MQ, Kang S, Cho NH.
Cancer Lett. 2011 Aug 1;307(1):62-71.

 

Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
Shim HS, Yoon BS, Cho NH.
Hum Pathol. 2009 May;40(5):693-8.

 

The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Shin JI, Song KS, Kim H, Cho NH, Kim J, Kim HS, Lee JS.
Br J Dermatol. 2011 Jun;164(6):1348-55.

 

CD24(+) ovary cancer cells exhibit an invasive mesenchymal phenotype.
Kang KS, Choi YP, Gao MQ, Kang S, Kim BG, Lee JH, Kwon MJ, Shin YK, Cho NH.
Biochem Biophys Res Commun. 2013 Mar 8;432(2):333-8.

 

Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer.
Choi YP, Kim BG, Gao MQ, Kang S, Cho NH.
Biochem Biophys Res Commun. 2012 Oct 26;427(3):642-8.

 

Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
Kim SH, Cho NH, Kim K, Lee JS, Koo BS, Kim JH, Chang JH, Choi EC.
J Surg Oncol. 2006 Mar 15;93(4):330-7.